PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,139 | +115.3% | 2,140 | +119.5% | 0.00% | – |
Q2 2023 | $6,104 | +67722.2% | 975 | -45.5% | 0.00% | – |
Q1 2023 | $9 | -91.4% | 1,788 | -85.2% | 0.00% | -100.0% |
Q4 2022 | $105 | -100.0% | 12,092 | -51.0% | 0.00% | -20.0% |
Q3 2022 | $294,000 | +46.3% | 24,694 | +75.1% | 0.01% | 0.0% |
Q2 2022 | $201,000 | +773.9% | 14,102 | +1199.7% | 0.01% | – |
Q1 2022 | $23,000 | -89.7% | 1,085 | -88.8% | 0.00% | -100.0% |
Q4 2021 | $224,000 | +113.3% | 9,680 | +173.6% | 0.00% | +33.3% |
Q3 2021 | $105,000 | +200.0% | 3,538 | +241.8% | 0.00% | +200.0% |
Q2 2021 | $35,000 | -61.5% | 1,035 | -62.7% | 0.00% | -50.0% |
Q1 2021 | $91,000 | +237.0% | 2,772 | +531.4% | 0.00% | +100.0% |
Q4 2020 | $27,000 | – | 439 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $74,726,000 | 44.17% |
Euclidean Capital LLC | 2,336,909 | $53,983,000 | 30.69% |
OUP Management Co., LLC | 989,232 | $22,851,000 | 10.30% |
Nextech Invest Ltd. | 1,385,807 | $32,012,000 | 8.43% |
Boxer Capital, LLC | 2,838,236 | $65,563,000 | 2.55% |
PERSONAL CFO SOLUTIONS, LLC | 550,342 | $12,713,000 | 2.38% |
Orbimed Advisors | 7,330,423 | $169,333,000 | 2.18% |
Asymmetry Capital Management, L.P. | 97,680 | $2,256,000 | 1.20% |
RTW INVESTMENTS, LP | 2,980,960 | $68,860,000 | 1.01% |
HighVista Strategies LLC | 39,777 | $919,000 | 0.73% |